X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38024) 38024
Newspaper Article (1615) 1615
Newsletter (498) 498
Magazine Article (239) 239
Book Chapter (207) 207
Transcript (43) 43
Book / eBook (26) 26
Dissertation (18) 18
Trade Publication Article (18) 18
Web Resource (15) 15
Book Review (12) 12
Conference Proceeding (11) 11
Reference (10) 10
Report (9) 9
Streaming Video (4) 4
Government Document (3) 3
Publication (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22325) 22325
animals (18997) 18997
female (14025) 14025
immunology (12013) 12013
vaccines (11099) 11099
vaccination (9960) 9960
viruses (9676) 9676
male (9301) 9301
mice (8389) 8389
infections (7683) 7683
infectious diseases (7374) 7374
antibodies, viral - blood (7061) 7061
immunization (7051) 7051
virology (6685) 6685
antibodies (6524) 6524
health aspects (6436) 6436
adult (6193) 6193
viral vaccines - administration & dosage (5989) 5989
infection (5929) 5929
medicine, research & experimental (5261) 5261
microbiology (5132) 5132
research (4728) 4728
viral vaccines - immunology (4700) 4700
proteins (4584) 4584
viral infections (4567) 4567
research article (4405) 4405
antigens (4261) 4261
virus diseases (4125) 4125
vaccine (4098) 4098
middle aged (3963) 3963
adolescent (3934) 3934
influenza (3904) 3904
immune response (3782) 3782
medicine (3764) 3764
analysis (3718) 3718
mice, inbred balb c (3713) 3713
child (3523) 3523
immunogenicity (3500) 3500
immunity (3450) 3450
infant (3374) 3374
multidisciplinary sciences (3339) 3339
prevention (3259) 3259
viral antibodies (3139) 3139
child, preschool (2931) 2931
veterinary sciences (2870) 2870
influenza vaccines - immunology (2813) 2813
medical research (2813) 2813
allergy and immunology (2812) 2812
science (2794) 2794
antibodies, viral - immunology (2786) 2786
influenza vaccines - administration & dosage (2685) 2685
children (2667) 2667
viral diseases (2648) 2648
studies (2514) 2514
immune system (2503) 2503
virus (2461) 2461
public health (2435) 2435
disease (2428) 2428
epidemiology (2339) 2339
hiv (2338) 2338
t cells (2322) 2322
young adult (2276) 2276
lymphocytes (2264) 2264
enzyme-linked immunosorbent assay (2249) 2249
risk factors (2227) 2227
biology and life sciences (2147) 2147
medicine and health sciences (2126) 2126
viral vaccines (2107) 2107
clinical trials (2095) 2095
aged (2091) 2091
care and treatment (2064) 2064
neutralization tests (2059) 2059
disease models, animal (2049) 2049
mortality (2039) 2039
biology (2009) 2009
viral load (2003) 2003
biotechnology & applied microbiology (2002) 2002
immune-responses (1980) 1980
human immunodeficiency virus--hiv (1976) 1976
protection (1956) 1956
cancer (1949) 1949
time factors (1947) 1947
dendritic cells (1921) 1921
immunoglobulins (1909) 1909
efficacy (1908) 1908
antibodies, viral - biosynthesis (1885) 1885
safety (1878) 1878
gene expression (1870) 1870
influenza vaccines (1845) 1845
dna (1843) 1843
hepatitis (1823) 1823
pathogens (1819) 1819
epidemics (1817) 1817
influenza, human - prevention & control (1802) 1802
vaccines, synthetic - immunology (1795) 1795
antibodies, viral - analysis (1748) 1748
cell line (1741) 1741
pandemics (1718) 1718
mice, inbred c57bl (1714) 1714
deoxyribonucleic acid--dna (1684) 1684
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39172) 39172
Russian (495) 495
German (402) 402
French (247) 247
Chinese (145) 145
Japanese (145) 145
Portuguese (106) 106
Spanish (102) 102
Italian (73) 73
Bulgarian (67) 67
Dutch (61) 61
Swedish (53) 53
Polish (44) 44
Czech (33) 33
Danish (33) 33
Norwegian (33) 33
Hungarian (16) 16
Romanian (9) 9
Slovak (9) 9
Turkish (8) 8
Croatian (5) 5
Finnish (5) 5
Hebrew (5) 5
Serbian (4) 4
Arabic (3) 3
Ukrainian (2) 2
Korean (1) 1
Lithuanian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Virology, ISSN 0022-538X, 10/2011, Volume 85, Issue 20, pp. 10605 - 10616
Journal Article
Vaccine, ISSN 0264-410X, 09/2018, Volume 36, Issue 37, pp. 5519 - 5523
A newly developed bovine-human reassortant pentavalent vaccine (BRV-PV, ROTASIIL®) was tested for its potential effect on the immunogenicity of concomitantly administered EPI vaccines in infants in a randomized controlled study in India... 
Bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) | Immune response | Interference | DTwP-HepB-Hib vaccine | Oral polio vaccine (OPV) | MEDICINE, RESEARCH & EXPERIMENTAL | Bovine-human reassortant pentavalent | rotavirus vaccine (BRV-PV) | EFFICACY | ORAL POLIOVIRUS | IMMUNOLOGY | TRIAL | IMPACT | MONOVALENT | BIVALENT | Immunogenicity, Vaccine | Poliovirus Vaccine, Oral - immunology | Immunoglobulin G - blood | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Male | Haemophilus Vaccines - administration & dosage | Poliovirus Vaccine, Oral - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Reassortant Viruses - immunology | Cattle | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Vaccines, Attenuated - administration & dosage | Female | Immunization Schedule | Rotavirus Vaccines - administration & dosage | Rotavirus Vaccines - immunology | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Attenuated - immunology | Animals | Hepatitis B Vaccines - immunology | Rotavirus Infections - prevention & control | Analysis | Vaccines | Laboratories | Immunoglobulin G | Vaccination | Antibodies | Viruses | Infants | Pertussis | Confidence intervals | Hepatitis | Randomization | Poliomyelitis | Population | Hepatitis B virus | Age | Antigens | Diphtheria | Whooping cough | Immunogenicity | Lymphocytes B | Tetanus | Binding sites | Hepatitis B
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 25, pp. 4264 - 4273
Abstract Tetravalent meningococcal serogroups ACWY conjugate vaccines will provide an advantage to those at most risk of invasive meningococcal disease... 
Allergy and Immunology | Tetravalent meningococcal vaccine | Hexavalent vaccine | Conjugate vaccine | DTaP-HBV-IPV/Hib combination vaccine | Bactericidal activity | MEDICINE, RESEARCH & EXPERIMENTAL | NEISSERIA-MENINGITIDIS | PREVENTION | IMMUNOSORBENT-ASSAY ELISA | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | TODDLERS | CAPSULAR POLYSACCHARIDE | IMPACT | INFLUENZAE TYPE-B | DISEASE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Female | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Tetanus Toxoid - adverse effects | Haemophilus Vaccines - immunology | Tetanus Toxoid - administration & dosage | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Tetanus Toxoid - immunology
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 3, pp. 313 - 319
...) vaccine with MF59 or saline placebo at 0, 1 and 6 months. • The vaccine was generally well tolerated, although local and systemic adverse events were significantly more common in the vaccine group... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | adolescent | vaccine | cytomegalovirus
Journal Article
Journal Article
Human vaccines & immunotherapeutics, ISSN 2164-554X, 2017, Volume 13, Issue 1, pp. 180 - 185
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 20, pp. 2379 - 2386
Highlights • ProQuad® and hexavalent vaccine immunogenicity is similar if given together or alone. • ProQuad... 
Allergy and Immunology | ProQuad® immunization | Rubella | Measles | ClinicalTrials.gov NCT: 00432042 | Varicella | Mumps | Hexavalent vaccine | ProQuad ® immunization | MEDICINE, RESEARCH & EXPERIMENTAL | PEDIATRIC COMBINATION VACCINES | MMRV VACCINATION | RISK | FEBRILE SEIZURES | IMMUNOLOGY | ProQuad (R) immunization | ADVISORY-COMMITTEE | IMPACT | RECOMMENDATIONS | Immunization, Secondary - adverse effects | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccination | Infant | Male | Haemophilus Vaccines - administration & dosage | Haemophilus influenzae type b - immunology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Immunization Schedule | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Chickenpox Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox Vaccine - administration & dosage | Haemophilus Vaccines - immunology | Measles-Mumps-Rubella Vaccine - adverse effects | Measles-Mumps-Rubella Vaccine - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Bacterial - immunology | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology | Chickenpox Vaccine - immunology | Infants | Safety and security measures | Vaccines | Schedules | Immunization | Chicken pox | Infections | Diphtheria | Whooping cough | Hepatitis | Poliomyelitis | Influenza | Response rates | Tetanus
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 35, pp. 6042 - 6048
Abstract Two randomized trials of 13-valent pneumococcal conjugate vaccine (PCV13) relative to PCV7 evaluated the immune responses of coadministered antigens comprising Infanrix... 
Allergy and Immunology | 13-valent pneumococcal conjugate vaccine | Infants | Pneumococcal vaccination | MEDICINE, RESEARCH & EXPERIMENTAL | MENINGITIS | STREPTOCOCCUS-PNEUMONIAE | EFFICACY | SAFETY | DISEASE | IMMUNOLOGY | REACTOGENICITY | DECLINE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Pneumococcal Vaccines - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Double-Blind Method | Drug Administration Schedule | Hepatitis B Vaccines - administration & dosage | Treatment Outcome | Haemophilus Vaccines - immunology | Spain | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Hepatitis B Vaccines - immunology | Germany | Whooping-cough | Antigens | Hemophilus infections | Vaccination | Vaccines | Drug therapy, Combination | Diphtheria | Hepatitis B | Proteins | Studies | Confidence intervals | Immunization | Aluminum | Ear diseases | Meningitis | Tetanus | Streptococcus infections
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 3, pp. 524 - 532
...) nanoparticle vaccine. ► The vaccine was well-tolerated and no related SAEs were observed... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
Pediatrics, ISSN 0031-4005, 01/2009, Volume 123, Issue 1, pp. 301 - 312
OBJECTIVE. Our goal was to compare the safety and immunogenicity of a combination vaccine (DTaP5-IPV-Hib; Pentacel... 
Vaccines combined | Poliovirus vaccine inactivated | Diphtheria-tetanus-acellular pertussis vaccines | Haemophilus influenzae vaccines | poliovirus vaccine inactivated | UNITED-STATES | DIPHTHERIA | ACELLULAR PERTUSSIS-VACCINE | COMBINATION VACCINES | TETANUS TOXOIDS | vaccines combined | CHILDREN | TOXOID CONJUGATE VACCINE | diphtheria-tetanus-acellular pertussis vaccines | INACTIVATED POLIOVIRUS | PEDIATRICS | WHOLE-CELL | B CONJUGATE | Diphtheria-Tetanus-Pertussis Vaccine | Immunization, Secondary - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | United States | Humans | Vaccines, Conjugate - adverse effects | Child, Preschool | Infant | Male | Bacterial Vaccines - pharmacokinetics | Vaccines, Combined - administration & dosage | Antibodies, Viral - blood | Vaccines, Combined - pharmacokinetics | Antibodies, Bacterial - biosynthesis | Female | Immunization Schedule | Poliovirus Vaccine, Inactivated - pharmacokinetics | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Child | Antibodies, Viral - biosynthesis | Vaccines, Conjugate - metabolism | Diphtheria-Tetanus-acellular Pertussis Vaccines - pharmacokinetics | Bacterial Vaccines - adverse effects | Immunization, Secondary - methods | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Bacterial Vaccines - administration & dosage | Haemophilus Vaccines | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Therapeutic Equivalency | Pertussis vaccines | Viral antibodies | Demographic aspects | Hib vaccines | Antibodies | Physiological aspects | Dosage and administration | Research | Clinical trials | Pediatrics | Vaccines | Safety | Comparative analysis
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 27, pp. 4007 - 4016
Highlights ► Inactivated whole viral (IWV) vaccines conferred good protection against IPN... 
Allergy and Immunology | Inactivated whole virus | Vaccine | IPNV | PLGA nanoparticles | Strain | Recombinant | MEDICINE, RESEARCH & EXPERIMENTAL | STRUCTURAL PROTEIN VP2 | PARTICLES | PROTECTION | SP SEROTYPE | IMMUNOLOGY | VIRULENCE | FORMULATION | RESPONSES | IMMUNOHISTOCHEMISTRY | EPITOPES | Vaccines, DNA - genetics | Vaccines, Subunit - genetics | Viral Vaccines - genetics | Vaccines, DNA - immunology | Drug Carriers - administration & dosage | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Vaccination - methods | Bacterial Toxins - genetics | Vaccines, Inactivated - genetics | Birnaviridae Infections - prevention & control | Salmo salar | Vaccines, Synthetic - genetics | Vaccines, Subunit - immunology | Birnaviridae Infections - veterinary | Fish Diseases - prevention & control | Viral Vaccines - administration & dosage | Infectious pancreatic necrosis virus - immunology | Vaccines, Inactivated - immunology | Animals | Fish Diseases - virology | Pseudomonas aeruginosa - genetics | Vaccines, Inactivated - administration & dosage | Escherichia coli - genetics | Vaccines, Subunit - administration & dosage | Survival Analysis | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Viral Vaccines - immunology | Virus diseases | Antigens | Salmon | Analysis | Universities and colleges | Vaccines | Comparative analysis | Health aspects | Studies | Proteins | Nanoparticles | Fish | Viruses | Infections | Deoxyribonucleic acid--DNA
Journal Article